{"disease":{"id":"urinary-bladder-overactive","name":"urinary bladder overactive"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01972841","title":"This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3527,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT00688688","title":"Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2792,"lead_sponsor_name":"Astellas Pharma Inc","has_results":true},{"nct_id":"NCT00689104","title":"Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2336,"lead_sponsor_name":"Astellas Pharma Inc","has_results":true},{"nct_id":"NCT01908829","title":"A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2174,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":true},{"nct_id":"NCT00662909","title":"A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2149,"lead_sponsor_name":"Astellas Pharma Inc","has_results":true},{"nct_id":"NCT00912964","title":"A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2030,"lead_sponsor_name":"Astellas Pharma Inc","has_results":true},{"nct_id":"NCT01638000","title":"A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1887,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":true},{"nct_id":"NCT02045862","title":"A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1829,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT02386072","title":"A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)","phase":"","overall_status":"COMPLETED","enrollment_count":1524,"lead_sponsor_name":"Astellas Scientific & Medical Affairs, Inc.","has_results":false},{"nct_id":"NCT01314872","title":"A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1395,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01340027","title":"A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1307,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT00966004","title":"A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1139,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT01043666","title":"A Study of YM178 in Subjects With Symptoms of Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1126,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03807024","title":"Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women","phase":"","overall_status":"COMPLETED","enrollment_count":1071,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT02320773","title":"A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":863,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT00527033","title":"A Study of YM178 in Patients With Symptomatic Overactive Bladder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":842,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT03560778","title":"Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients","phase":"","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03043287","title":"Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)","phase":"","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"Allergan","has_results":false},{"nct_id":"NCT05968885","title":"Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Mackay Memorial Hospital","has_results":false},{"nct_id":"NCT06479720","title":"Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Mackay Memorial Hospital","has_results":false},{"nct_id":"NCT01604928","title":"Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":false},{"nct_id":"NCT02820844","title":"Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07114640","title":"The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT05250908","title":"INTIBIA Pivotal Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":208,"lead_sponsor_name":"Coloplast A/S","has_results":false},{"nct_id":"NCT07209397","title":"Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women","phase":"NA","overall_status":"RECRUITING","enrollment_count":202,"lead_sponsor_name":"InMode MD Ltd.","has_results":false},{"nct_id":"NCT06210477","title":"Association With Low Compliance Bladder in Women With LUTS","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06197295","title":"Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Mackay Memorial Hospital","has_results":false},{"nct_id":"NCT01565707","title":"A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":189,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT06201013","title":"Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Children's Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT04420533","title":"Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT01655069","title":"A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Astellas Pharma Europe B.V.","has_results":true},{"nct_id":"NCT03052764","title":"Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03681678","title":"Laser Therapy for Treatment of Urogenital Symptoms in Women","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Corewell Health East","has_results":true},{"nct_id":"NCT05328011","title":"Targeting Microbiota in Female Overactive Bladder Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT03520166","title":"Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Fisioterapia Pélvica Avanzada Madrid, SRL","has_results":false},{"nct_id":"NCT06921915","title":"Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Kathleen O'Connell","has_results":false},{"nct_id":"NCT06508944","title":"Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT05878951","title":"Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06933407","title":"Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Szeged University","has_results":false},{"nct_id":"NCT03519126","title":"Electrostimulation in the Treatment of Idiopathic Overactive Bladder","phase":"NA","overall_status":"TERMINATED","enrollment_count":67,"lead_sponsor_name":"Janaina Mayer de Oliveira Nunes","has_results":false},{"nct_id":"NCT03625492","title":"Fluids Affecting Bladder Urgency and Lower Urinary Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT07366918","title":"Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder","phase":"NA","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT06349694","title":"Comparison of the Efficacy of Transcutaneos Nerve Stimulations in Women With Idiopathic Overactive Bladder","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT04305743","title":"Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of South Florida","has_results":false},{"nct_id":"NCT02097121","title":"OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01558856","title":"Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04599283","title":"BE Technologies Mobile Uroflowmetry Validation Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"BE Technologies Inc","has_results":false},{"nct_id":"NCT05416450","title":"The Efficacy of Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder","phase":"NA","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT01262391","title":"Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT05668715","title":"Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Pamukkale University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}